22nd Century Group, Inc. (XXII)
22nd Century Group, Inc. is a biotechnology company which develops smoking cessation products for those smokers, who refuse to quit smoking; and modified risk tobacco products that reduce exposure to smoke toxins compared to conventional cigarettes. The company?s products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. It is also developing modified risk cigarettes, such as BRAND A, which has approximately 95% less nicotine than tobacco in cigarettes marketed as ?light? cigarettes; and BRAND B cigarettes? smoke contains the lowest amount of tar per milligram of nicotine. 22nd Century Group,...
In the last trading session, the share price of 22nd Century Group, Inc. (OTC:XXII) stock hit a new six-month low, which however, happened with some delay as the only reason for now seems to be the latest press release of the company that came out on Monday afternoon.read more
|There are no comments.|